Svar på skriftligt spörsmål om störningar i tillgången på östrogenpreparat

This procedure is a written response from a government official to a question raised in parliament. It addresses issues concerning the availability of estrogen-based medications, which are crucial for hormone replacement therapy, particularly for women experiencing menopause. The response is relevant to patients requiring estrogen treatments, healthcare providers, and pharmaceutical suppliers. It aims to clarify the situation regarding drug access and potential disruptions in the supply chain.